Plasma levels of t-Tau were most strongly correlated with MMSE scores (Figure 1), suggesting that plasma t-Tau levels are more closely associated with cognitive impairment than Aβ1-42 or p-Tau levels. The gene discussed is MAPT; the disease is Cognitive impairment.